Viewing Study NCT01527435


Ignite Creation Date: 2025-12-24 @ 10:37 PM
Ignite Modification Date: 2025-12-28 @ 7:49 AM
Study NCT ID: NCT01527435
Status: COMPLETED
Last Update Posted: 2016-04-06
First Post: 2012-01-27
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Addition of 20mg/Day Zeaxanthin to Triple Therapy Treatment Options for Age Related Macular Degeneration (ARMD)
Sponsor: The Retina Center of St. Louis County, PC
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Outcomes Module Eligibility Module Contacts Locations Module References Module